Daniel Nettersheim

27PUBLICATIONS
59CO-AUTHORS
Solid tumoursMolecular targetsHaematological tumoursPredictive and prognostic markersPhysical properties of materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 22, 2026
A Spotlight on Yolk-sac Tumors: Molecular Pathology, Current Diagnostics, and Novel Therapeutics.

|Apr 02, 2026
The Functional Role and Molecular Characterization of the Therapeutic Target CLDN6 in Germ Cell Tumors.

Jule Zwick, Margaretha A Skowron, Gereon Poschmann

|Dec 12, 2025
Molecular pathology of testicular germ cell tumours: an update for practicing pathologists.

Alexander Fichtner, Stefanie Zschäbitz, Daniel Nettersheim

|Mar 03, 2025
Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistance.

Mara Kotthoff, Margaretha A Skowron, Felix Bremmer

|Dec 20, 2024
The New Tumour Biomarker miRNA-371-3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell Lines.

Richard Weiten, Theadora Engler, Hubert Schorle

|Jun 26, 2024
Pathogenesis and pathobiology of testicular germ cell tumours: a view from a developmental biological perspective with guidelines for pathological diagnostics.

Alexander Fichtner, Daniel Nettersheim, Felix Bremmer

Pageof 5

Frequent Collaborators

8 joint publications

Margaretha A Skowron

7 joint publications

Felix Bremmer

6 joint publications

Hubert Schorle

4 joint publications

Peter Albers